950 — Lees Pharmaceutical Holdings Share News
0.000.00%
Last trade - 00:00- HK$624.17m
- HK$438.96m
- HK$1.44bn
Brief: Lee's Pharmaceutical Posts FY Profit Attributable HK$129.3 Mln Vs HK$125.6 Mln
Brief: Lee's Pharmaceutical Says Got NMPA Approval For IND Application Of GCC-4401C
Brief: Sorrento Therapeutics Says China's National Medical Products Administration Clears Lee's Pharmaceutical To Conduct Phase III Trial Of Socazolimab
Brief: Lee's Pharmaceutical Says Socazolimab Obtained Phase III Clinical Trial Approval From NMPA
Brief: Lee's Pharmaceutical's Unit & Kunming Baker Norton Pharmaceutical Executed A Distribution Deal
Brief: Lee's Pharma's Unit Got Breakthrough Therapy Designation By NMPA For Oncology Product
Brief: Lee's Pharmaceutical Says Fondaparinux Sodium Injection Got Approval For Drug Registration From China's NMPA
Brief: Lee's Pharmaceutical Says Associated Co Signed MoU With Singapore Eye Research Institute
Brief: Lee's Pharmaceutical Holdings Says Unit To Advance To China Oncology Focus Ltd US$6 Mln And RMB5 Mln Loan
Brief: Lee's Pharmaceutical Holdings Updates On An Investigational Gynecology Drug Product
Lee's Pharmaceutical hits 2-month high on unit's listing plan
Brief: Lee's Pharmaceutical Says Application Made For Proposed Spin-Off Of Zhaoke Ophthalmology
Brief: Lee's Pharmaceutical Says Trazodone Hydrochloride Tablet Obtained Drug Registration Certificate From NMPA
Brief: Lee's Pharma Updates On Possible Spin-Off And Listing of Zhaoke Ophthalmology
Brief: Lee's Pharmaceutical Says Staccato Fentanyl Granted Approval For Trials By NMPA
Brief: Lee's Pharma Says Zhaoke (Hk) Ophthalmology Pharma & Nevakar Entered Licensing Agreement
Brief: Lee's Pharmaceutical Says Unit To Advance Powder Pharmaceuticals Inc Additional Loan Of HK$15 Million
Brief: Lee's Pharmaceutical Says Phase III Trial Of Staccato Loxapine Meets Primary Endpoint
Brief: Lee's Pharmaceutical Says Investigational NDA Of Staccato Fentanyl Accepted By NMPA